Loading
Founded the European Thoracic Oncology Platform and leads the merged ETOP IBCSG academic trials foundation.
Rolf Stahel founded the European Thoracic Oncology Platform in 2009 to run academic lung cancer and mesothelioma trials across Europe, including the SAKK mesothelioma surgery trial, BELIEF, SPLENDOUR and the ETOP-led collaborations on ALK and EGFR disease, and now leads the foundation formed by its merger with the International Breast Cancer Study Group. He has been president of ESMO and led the Zurich lung cancer programme.
Shares ETOP IBCSG Partners Foundation, Non-small-cell lung cancer.
Shares ETOP IBCSG Partners Foundation, Mesothelioma, Non-small-cell lung cancer and the tag cooperative-group.
Shares Mesothelioma, Non-small-cell lung cancer and the tag thoracic.
Shares Mesothelioma, Non-small-cell lung cancer.
Shares ETOP IBCSG Partners Foundation and the tag cooperative-group.
Shares ETOP IBCSG Partners Foundation and the tag cooperative-group.
Shares Mesothelioma, Non-small-cell lung cancer.